Home1IOVA • BIT
add
Iovance Biotherapeutics Inc
Previous close
€1.90
Day range
€2.02 - €2.02
Year range
€1.10 - €18.79
Market cap
832.26M USD
Avg Volume
1.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 67.46M | 15.20% |
Operating expense | 118.74M | 10.15% |
Net income | -91.25M | -9.23% |
Net profit margin | -135.28 | 5.18% |
Earnings per share | -0.25 | 10.71% |
EBITDA | -80.70M | -0.24% |
Effective tax rate | 2.57% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 301.18M | -24.23% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 698.49M | — |
Shares outstanding | 361.85M | — |
Price to book | 0.93 | — |
Return on assets | -24.76% | — |
Return on capital | -29.79% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -91.25M | -9.23% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Founded
2007
Headquarters
Website
Employees
838
